Jay R. Luly - President and CEO, Director at Enanta Pharmaceuticals Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Stock Symbol
ENTA on Nasdaq
All Insider Reports
All Insider Reports

Jay R. Luly - trading volume in the past year for Enanta Pharmaceuticals Inc

Holdings reported by Jay R. Luly for Enanta Pharmaceuticals Inc

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 811K $10.1M $12.41 Feb 12, 2024 Direct
Stock Option (right to buy) 264K Nov 22, 2023 Direct Common Stock

Transactions reported by Jay R. Luly for Enanta Pharmaceuticals Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.